Mesoblast’s Ryoncil: US FDA Changed Its Mind On Need For A Randomized Trial

 
• By Sue Sutter
Ryoncil DRP efficacy story
The quantum of efficacy evidence was a point of debate in the Ryoncil review. (Nancy Pham)

More from Drug Review Profiles

More from Approvals